Omar Hamdy
Dr Omar Hamdy, MD is an expert in Oncology at Mansoura University (Egypt). As of November 2026, ScienceLeadR ranks Omar Hamdy in the top 1% of experts in Egypt for Thyroid Neoplasms, Breast Diseases and Breast Neoplasms. Omar Hamdy has authored 147 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 538 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Surgery - Gynecology - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2011 - 2026Faculty of Medicine - Mansoura University
2016 - 2026
Mansoura University - Lecturer of surgical oncology
2018 - 2026
Number : 147
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Clinical Outcomes and Prognostic Factors of Kaposi Sarcoma in a Non-Endemic Region: A Retrospective Cohort Study. PMID 43026879 — radiotherapy, sarcoma, kaposi, lymph nodes, cohort studies, drug therapy, sarcoma, neoplasm metastasis, lymph, diagnosis, therapeutics, wounds and injuries, prognosis, chemotherapy | Cancers (Basel) | 2026 | 0 |
| International Initiative on a Refined Staging System for Medullary Thyroid Cancer: A Multinational Multicenter Study. PMID 42981561 — neoplasms, thyroid gland, thyroid neoplasms | J Clin Oncol Top journal | 2026 | 0 |
| Postoperative Vasoactive Exposure Patterns and Outcomes After Non-Cardiac Surgery: A Prespecified Analysis of the SQUEEZE Cohort. PMID 42860683 — mortality, anesthesiology, classification, kidney, length of stay, cluster analysis, postoperative period, therapeutics, hemodynamics, acute kidney injury, vasoconstrictor agents | Acta Anaesthesiol Scand | 2026 | 0 |
| Biological fact versus technical artifact in ER negative PR positive breast cancer. PMID 42616285 — breast neoplasms, neoplasms, breast | Discov Oncol | 2026 | 0 |
| Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries. PMID 42483900 — global health, emergencies, surgical procedures, operative, neoplasms, income, cohort studies, colorectal neoplasms | BJS Open | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 9
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients NCT06176339 — breast neoplasms, paclitaxel, pentoxifylline, cyclophosphamide, doxorubicin, neoplasms, tablets, drug therapy, breast, therapeutics, chemotherapy, female | Phase 2 | Active not recruiting | 2023 |
LeadR Networks
Main global connection map